Krebs Biochemicals & Industries Limited (BOM:524518)
58.77
-2.81 (-4.56%)
At close: Sep 11, 2026
Krebs Biochemicals & Industries Company Description
Krebs Biochemicals & Industries Limited engages in the manufacture of active pharmaceutical ingredients in India.
It offers androstenedione for steroid intermediate indications, as well as lovastatin and simvastatin for anti-cholesterol applications.
The company also develops amlodipine and telmisartan for anti-hypertension; cetirizine for antihistamine; orlistat for anti-obesity; serratiopeptidase for anti-inflammatory; and phenylephrine for cold and cough.
In addition, it provides contract manufacturing services for large pharmaceutical and multinational companies.
The company was incorporated in 1991 and is based in Visakhapatnam, India.
Krebs Biochemicals & Industries Limited
| Country | India |
| Founded | 1991 |
| Industry | Medicinal Chemicals and Botanical Products |
| Employees | 202 |
| CEO | Manish Jain |
Contact Details
Address: Kothapalli Village Visakhapatnam, 531031 India | |
| Phone | 91 91 2114 4984 |
| Website | krebsbiochem.com |
Stock Details
| Ticker Symbol | 524518 |
| Exchange | Bombay Stock Exchange |
| Fiscal Year | April - March |
| Reporting Currency | INR |
| SIC Code | 2833 |
Key Executives
| Name | Position |
|---|---|
| Manish Jain | Chief Executive Officer |
| Ritesh Jain | Chief Financial Officer |